Turkfleks %0.9 Sodium Chloride
NDC 85160-200
View dosage, usage, ingredients, routes, and UNII mappings.
Product Information
This product is EXCLUDED from the official NDC directory because the listing certification is expired.
Turkfleks %0.9 Sodium Chloride is a UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE-approved product labeled by Turk Ilac Ve Serum Sanayi Anonim Sirketi. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a product. This product entry covers the primary NDC 85160-200 and 7 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
NDC Product Code:
85160-200
Proprietary Name:
Turkfleks %0.9 Sodium Chloride
Product Type: [3]
EXPIRED PRODUCT and EXCLUDED from the NDC Directory
Code Navigator:
Labeler & Regulatory Data
Labeler Name: [5]
Labeler Code:
85160
Product Label ID:
Marketing Category: [8]
UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
Marketing Timeline
Start Marketing Date: [9]
01-15-2025
Listing Expiration Date: [11]
12-31-2026
Exclude Flag: [12]
E
Code Structure Chart
Product Details
What is NDC 85160-200?
The NDC code 85160-200 is assigned by the FDA to the product Turkfleks %0.9 Sodium Chloride. This pharmaceutical product is labeled by Turk Ilac Ve Serum Sanayi Anonim Sirketi and is currently categorized as listed product. In terms of distribution, this product is available in 7 different package configurations. Beyond standard identification, this entry provides technical data including pharmacologic classes, UNII ingredient references, and RxNorm cross-referencing for healthcare systems.
What are the uses of this product?
The solution is contraindicated in patients with hypernatremia or hyperchloremia. It should also not be used in cases where sodium or chloride administration is clinically harmful.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- CHLORIDE ION (UNII: Q32ZN48698)
- CHLORIDE ION (UNII: Q32ZN48698) (Active Moiety)
What is the NDC to RxNorm Crosswalk for this product?
RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:
- RxCUI: 1807627 - sodium chloride 0.9 % in 150 ML Injection
- RxCUI: 1807627 - 150 ML sodium chloride 9 MG/ML Injection
- RxCUI: 1807627 - 150 ML NaCl 9 MG/ML Injection
- RxCUI: 1807627 - sodium chloride 0.9 % per 150 ML Injection
- RxCUI: 1807631 - sodium chloride 0.9 % in 50 ML Injection
* Please review the full disclaimer at the bottom of this page.
Product & Regulatory Definitions
What is the Labeler Name? Name of Company corresponding to the labeler code segment of the Product NDC.
What is the Marketing Category? Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
What is the Start Marketing Date? This is the date that the labeler indicates was the start of its marketing of the drug product.
What is the Listing Expiration Date? This is the date when the listing record will expire if not updated or certified by the product labeler.
What is the NDC Exclude Flag? This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions, or because the listing certification is expired, or because the listing data was inactivated by FDA, or because it was discontinued by the labeler. Possible values in this field are: "D", "E", "I", "N", "U".
